Sidney Kimmel Cancer Center- Thomas Jefferson University

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Nivolumab and BMS-986253 for Hormone-Sensitive Prostate Cancer (MAGIC-8)	Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate adenocarcinoma, prostate cancer, prostate disorder	Active, not recruiting	Phase 1 / Phase 2	2025-04-29		NCT03689699

Clinical trials